Kordata Dynamics has successfully closed its first funding round, a pre-seed raise from MAVRK Celestia Fund, Kern Venture Group, and Digital Neural Infrastructure Holdings. The company, a spin-out from BIOS Health, plans to leverage this capital to advance its AI-powered platform for precision clinical trials. This funding will support Kordata's mission to deliver fast, high-quality results in complex therapeutic areas.